PFIZER KOREA

Pfizer Korea is primarily a sales, marketing, and distribution subsidiary for Pfizer's pharmaceutical products in South Korea. It operates more as a trading and distribution company, bringing global Pfizer innovations to the Korean market, rather than functioning as a manufacturing factory itself within Korea.

Company Introduction:

Pfizer Korea, a wholly-owned subsidiary of Pfizer Inc., one of the world's leading biopharmaceutical companies, has been a significant contributor to the health and well-being of the Korean population for decades. Established to serve the South Korean market, Pfizer Korea is responsible for the import, marketing, and distribution of a wide range of innovative medicines and vaccines across various therapeutic areas, including oncology, inflammation and immunology, rare diseases, internal medicine, and vaccines. The company is dedicated to applying science and its global resources to improve health and wellness at every stage of life. It focuses on developing and delivering breakthrough therapies, engaging in clinical research, and fostering partnerships with healthcare professionals and organizations to address unmet medical needs and advance healthcare in Korea. Pfizer Korea upholds its parent company's commitment to ethical practices, patient safety, and corporate social responsibility.

Here are some of the products manufactured or sold by Pfizer Korea:

* Comirnaty (COVID-19 vaccine)

* Paxlovid (COVID-19 treatment)

* Prevenar 13 (Pneumococcal vaccine)

* Enbrel (etanercept, for rheumatoid arthritis)

* Xeljanz (tofacitinib, for rheumatoid arthritis)

* Ibrance (palbociclib, for breast cancer)

* Sutent (sunitinib, for cancer)

* Lyrica (pregabalin, for neuropathic pain and epilepsy)

* Viagra (sildenafil, for erectile dysfunction)